Lei Stanley Qi

Lei Stanley Qi
Lei Stanley Qi
Born	Qi Lei (亓磊); Shandong, China
Nationality	Chinese
Alma mater	Tsinghua University (B.A.); UC Berkeley (Ph.D.);
Known for	CRISPRi, dCas9，CRISPR imaging，CRISPR-GO
Awards	Sloan Research Fellowship (2017); Pew Scholar (2016); NIH Directors Early Independence Award (2013);
	Scientific career
Fields	Genome engineering, Synthetic Biology
Institutions	Stanford, Chemical and Systems Biology
Academic advisors	Adam Arkin, Jennifer Doudna
Website	med.stanford.edu/qilab.html; qi.ucsf.edu;

Lei "Stanley" Qi (Chinese: 亓磊; pinyin: Qí Lěi) is an associate professor in the department of bioengineering, and the department of chemical and systems biology at Stanford University. Qi led the development of the first catalytically dead Cas9 lacking endonuclease activity (dCas9), which is the basis for CRISPR interference (CRISPRi). His laboratory subsequently developed CRISPR-Genome Organization (CRISPR-GO).

Qi is a co-inventor of the University of California patent on the CRISPR gene-editing technology.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.